Zenith Drugs Awarded ₹4.11 Crore Contract for Supply of Pharmaceutical Syrup by Karnataka State Medical Supplies Corporation
Zenith Drugs Limited has secured a significant tender award from the Karnataka State Medical Supplies Corporation Limited (KSMSCL), a Government of Karnataka undertaking. The contract involves the supply of pharmaceutical products, boosting the company's presence in the institutional pharmaceutical segment and reflecting increased trust from government healthcare agencies regarding the company's manufacturing quality and product execution.The order details involve supplying Montelukast and Levocetirizine Syrup to KSMSCL. This agreement represents a substantial addition to Zenith Drugs’ business portfolio, underscoring its capability to serve public healthcare institutions effectively.
Key details of the contract are presented in the table below:
| Detail | Information |
|---|---|
| Authority | Karnataka State Medical Supplies Corporation Limited (KSMSCL) |
| Product | Montelukast and Levocetirizine Syrup (1 x 60 ml bottle, containing Montelukast 4 mg and Levocetirizine 2.5 mg) |
| Quantity | 29,10,826 bottles |
| Order Value | ₹4.11 Crore approx. |
The acquisition of this order is part of the normal course of business for Zenith Drugs Limited and has been confirmed as non-related party transaction. The company anticipates that the execution of this contract will contribute positively to its revenues and strengthen its association with public healthcare institutions across India.
ZENITHDRUG Stock Price Movement
Shares of Zenith Drugs Limited are shedding 3.05% in live trading as of 1:46 PM, with the stock currently trading down to ₹41.30. Traded volume stands at 12,000 shares in the ongoing market session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.